• Keine Ergebnisse gefunden

ANALYSIS OF PERIPHERAL INFLAMMATORY T-CELL SUBSETS AND THEIR EFFECTOR FUNCTIONSIN PATIENTS WITH BIRDSHOT-RETINOCHOROIDITIS

N/A
N/A
Protected

Academic year: 2022

Aktie "ANALYSIS OF PERIPHERAL INFLAMMATORY T-CELL SUBSETS AND THEIR EFFECTOR FUNCTIONSIN PATIENTS WITH BIRDSHOT-RETINOCHOROIDITIS"

Copied!
1
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

www.bihealth.org

ANALYSIS OF PERIPHERAL INFLAMMATORY T-CELL SUBSETS AND THEIR EFFECTOR FUNCTIONS

IN PATIENTS WITH BIRDSHOT-RETINOCHOROIDITIS

Dominika Pohlmann

1

, Janine Trombke

2,3

, Lucie Loyal

3

, Julian Braun

3

, Uwe Pleyer

1

, Andreas Thiel

3

1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health

2Max-Delbrück Center for Molecular Medicine, Berlin, Germany

3Berlin-Brandenburg Center for Regenerative Therapies, Charite ́-Universitätsmedizin Berlin, Germany

1. nein, 2. nein, 3. Allergan, Bayer, 4. nein, 5. nein

To characterize and correlate inflammatory T cell subsets derived from peripheral blood mononucleated cells (PBMC) with clinical parameters of patients with birdshot-retinochoroiditis (BSRC).

PURPOSE

METHODS

RESULTS

Figure 1. Fundus photography (A) presents characteristic choroidal lesions in a birdshot- retinochoroiditis. Fluorescence angiogram (B) showing retinal vascular leakage and optic disc hyperfluorescence and indocyanine green angiogram (C) showing multiple hypofluorescent spots (dark dots) which represent an active disease. The second fundus photography (D) demonstrates brightened fundus, atrophic optic nerv, and choroidal scars. Fluorescence angiogram (E) showing no retinal vascular perfusion and indocyanine green angiogram (F) showing hypofluorescent areas as sign of atrophy.

In our pilot study, we examined 11 patients (22 eyes) with BSRC (HLA-A29 positive). Clinical examination and multimodal standard imaging with spectral domain optical coherence tomography, fluorescein angiography (FA), and indocyanine green angiography (ICGA) were performed to classify disease activity. Peripheral blood- derived CD4+ and CD8+ T cells were analyzed for their naïve, memory, and EMRA status by CD45RA and CCR7 expression using flow cytometry. The memory compartment was further subdivided into diverse functional subsets regarding the surface expression of 4 chemokine receptors (CCR4, CCR6, CCR10, CXCR3) and the functional profile assessed by intracellular cytokine staining.

We identified retinal vascular leakage on FA/ICGA as active disease in 10 eyes of 5 patients, while 12 eyes of 6 patients demonstrated no retinal leakage, but altered vascular architecture and retinal thinning as inactive, end-state disease group (Figure 1). The inactive, end- stage disease group revealed a significant accumulation of peripheral CD8+ effector memory T cells expressing CD45RA (TEMRA) in blood compared to active disease group (Figure 2). In the active disease group, we found decreased frequencies of Th2 (CCR6- CCR4+ CXCR3-) memory CD4+ T-cells accompanied by increased Th1 (CCR6- CCR4- CXCR3+) cell frequencies compared to healthy controls and the inactive disease group. Functional assays demonstrated impaired cytokine production of CD4+ and CD8+ memory T-cells in BSRC patients regardless of their treatment and stage of disease (Figure 3).

Our preliminary results revealed a Th1/Th2 imbalance in BSRC which may indicate autoimmune processes. High frequencies of CD8+ (TEMRA) could be an indicator for a poor prognostic outcome. In addition, decreased cytokine levels in the periphery are probably caused by immunosuppression or exhaustion of the T-cell subsets.

Accordingly, we propose to distinguish these cells ex vivo based on the expression of chemokine receptor instead of functional analyses.

These findings offer new insights into the immunological pathophysiology of BSRC disease and may help in defining new biomarkers for monitoring.

CONCLUSION

A B C

D E F

Figure 2. Exemplary analysis and gating strategy of CD8+ T-cell stages (A) and analysis of the proportion of peripheral CD8+ TEMRA (CCR7-CD45RA+) T cells (B) active and inactive disease, and healthy controls.

dominika.pohlmann@charite.de

Figure 3. Memory T-cells show reduced potential to exert effector function. The frequencies of IFN-γ, TNF-α, IL-2, IL-4, IL-17 and IL-22-producing CD45RO+ T-cells were determined after mitogenic stimulation (for 6h) via intracellular antibody labelling. (A) Shows the exemplary gating strategy of parental CD45RO+ T cells, of which the calculation of intracellularly stained cytokines is depicted in (B) and (C) among CD4+ and CD8+ memory T cells, respectively.

A B

A B

C D

IFN-γ TNF-α IL-2 IL-4 IL-17 IL-22

Referenzen

ÄHNLICHE DOKUMENTE

and HR, 0.51 versus 0.84, respectively). Cardiovascular death/MI/stroke: age, female, geographic region, weight, eGFR, inclusion criteria, ABI, Rutherford classification,

On the other hand, for high extraction drugs administered intravenously, a normal initial dose can be administered and the maintenance doses have to be reduced

Pharmaceutical companies should urged to provide kinetic data (especially hepatic extraction) used for classification of such drugs and to conduct kinetic studies for drugs

Further categorisation of the study subjects was as follows: (1) subjects from the employees group with defined symptoms of rosacea were classified rosacea patients; (2) subjects

We show that IR injury of the retina results in signifi- cant neuronal cell apoptosis with inner retinal thinning, a progressive and resolving innate immune response, and a

Interestingly, using the normal RT-PCR sensitivity TG mRNA transcripts are specific for thyroid tissue and detectable in the peripheral blood of controls and patients with

Other questionnaires included the Work Productivity and Activity Impairment (WPAI) question- naire [12], the Multidimensional Fatigue Inventory (MFI) [13], and the Short

A total of 56 patients undergoing neoadjuvant chemo- therapy and representing the placebo arm of the Gepar- Nuevo trial underwent immune monitoring on blood samples collected at